[Translated article] Knowledge of biological therapy in patients with immune-mediated diseases. BIOINFO study
In general, the level of knowledge prior to biological therapy in patients is acceptable, being higher in dosage and administration technique related-factors and what is related to the dosage and administration technique and where to find information related to the medication; the worst rated were those on biosimilars-related. The factor of being followed by rheumatology, was associated with better knowledge.
Authors
- Carlos Seguí-Solanes
- Joaquín Borrás‐Blasco (ORCID: https://orcid.org/0000-0003-0248-4208)
- Vicente Merino Bohórquez
- Esther Ramírez Herráiz (ORCID: https://orcid.org/0000-0003-3053-7426)
- Tomás Palanques-Pastor
- Silvia Ruiz‐Garcia (ORCID: https://orcid.org/0000-0001-7182-4654)
- Cristina C. Montes
- Lidia Estrada
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Universitario Virgen Macarena (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1016/j.farma.2024.08.002
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00